Approval · Notice of Compliance 2057 · 1999
VITRASERT: Notice of Compliance 2057
Issued January 14, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2057
- Date
- January 14, 1999
- Company
- Bausch & Lomb Surgical Inc.St. Louis, MO, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VITRASERT | 02233015 | Cancelled Post Market |
Medicinal ingredients
- GANCICLOVIR 4.5 MG per IMP